您当前位置: 首页  师资队伍  硕士生导师  药剂学

陆超

发布时间:2023-08-30 发布单位:药学院

1、个人简介:

陆超男,博士,暨南大学药学院副教授,硕士研究生导师,广州市增城区创新创业领军团队(人才)项目核心成员、暨南大学学科建设优秀青年骨干人才曾任美国南佛罗里达大学访问学者,中山大学药学院博士后。2020年进入暨南大学高端药物制剂研究院工作,师从药剂学吴传斌教授。主持国家自然科学基金、中国博士后科学基金、广州市基础研究计划基础与应用基础研究项目等多个项目。发表SCI50余篇,H-index=20,其中以第一/通讯作者在影响因子10以上杂志发表论文11篇,中科院1/TOP论文13篇,封面论文4篇;申请专利4项,其中2项获授权,参编专著2部,多次受邀进行学术报告。担任期刊VIEWActa Materia MedicaMaterials FutureshLife和《今日药学》的青年编委、Exploration推广编辑、Pharmaceutics专题顾问和Moleules客座编辑,多个SCI杂志的审稿人,国际控释协会、广东省药学会等学术组织会员,中国药物制剂大会、岭南国际药学大会组委会成员致力于推动高端药物制剂的产业化工作,与广州新济药业等国内知名企业保持良好的互动合作。近年来,指导多名本硕博学生开展学术研究,并获国家级“大创”项目资助、优秀毕业论文、优秀壁报奖等荣誉。


2讲授课程:

[1] 药学本科生课程:《药剂学》

[2] 药剂学研究生课程:《高等药剂学》、《药剂学概论》、《药剂学研究进展》、《科研论文写作》


3研究方向:

新型抗菌抗肿瘤材料及制剂的开发与应用,主要涉及新型纳微米药物可溶性微针贴片、可注射水凝胶等递药系统。


4主持的科研项目:

[1]国家自然科学基金青年基金项目(项目编号:81803467

[2]中国博士后科学基金面上项目(项目编号:2018M633259

[3]广东省感染病与分子免疫病理重点实验室专项项目(项目编号:GDKL202207

[4] 广州市基础研究计划基础与应用基础研究项目(项目编号:202102020887

[5]暨南大学学科建设优秀青年骨干项目(项目编号:/

[6] 暨南大学人才引进科研启动经费50万(项目编号:/

[7] 横向课题(项目编号:/


5代表性论文:

[1]Jingwen Deng#, Dongyi Xian#, Xiaopeng Cai#, Shaoxia Liao, Siqin Lei, Fengyan Han, Yandong An, Qing He, Guilan Quan, Chuanbin Wu, Tingting Peng,* Chao Lu*, and Honghe Zhang*. Surface-engineered vanadium carbide MXenzyme for anti-inflammation and photoenhanced antitumor therapy of colon diseases. AdvancedFunctional Materials, 2023, 2211846.IF=19.978

[2]Xiaoqian Feng#, Dongyi Xian#, Jintao Fu, Rui Luo, Wenhao Wang, Yuwei Zheng, Qing He, Zhan Ouyang, Shaobin Fang, Wancong Zhang, Daojun Liu, Shijie Tang, Guilan Quan, Jianfeng Cai, Chuanbin Wu, Chao Lu*, Xin Pan*. Four-armed host-defense peptidomimetics-augmented vanadium carbide MXene-based microneedle array for efficient photo-excited bacteria-killing. Chemical Engineering Journal, 2023, 456(15): 141121.IF=16.744

 [3]Yin Shi, Xiaoqian Feng, Liming Lin, Jing Wang, Jiaying Chi, Biyuan Wu, Guilin Zhou, Feiyuan Yu, Qian Xu, Daojun Liu, Guilan Quan, Chao Lu*, Xin Pan*, Jianfeng Cai*, Chuanbin Wu*. Virus-inspired surface-nanoengineered antimicrobial liposome: A potential system to simultaneously achieve high activity and selectivity. Bioactive Materials, 2021, 6(10): 3207-3217.IF=16.874

 [4]Maochao Zheng, Miao Pan, Wancong Zhang, Huanchang Lin, Shenlang Wu, Chao Lu*, Shijie Tang*, Daojun Liu*, Jianfeng Cai*. Poly(α-L-lysine)-based nanomaterials for versatile biomedical applications: Current advances and perspectives. Bioactive Materials, 2021, 6(7): 1878-1909.IF=16.874

 [5]Liming Lin, Jiaying Chi, Yilang Yan, Rui Luo, Xiaoqian Feng, Yuwei Zheng, Dongyi Xian, Xin Li, Guilan Quan, Daojun Liu, Chuanbin Wu, Chao Lu*, Xin Pan. Membrane-disruptive peptides/peptidomimetics-based therapeutics: Promising systems to combat bacteria and cancer in the drug-resistant era. Acta Pharmaceutica Sinica B, 2021, 11(9): 2609-2644.IF=14.903

 [6] Tingting Peng, Yangyan Chen, Wanshan Hu, Yao Huang, Minmin Zhang, Chao Lu*, Xin Pan*, Chuanbin Wu*. Microneedles for enhanced topical treatment of skin disorders: Applications, challenges, and prospects.Engineering,2023, DOI: 10.1016/j.eng.2023.05.009. IF=12.834

 [7] Feng Li#, Liming Lin#, Jiaying Chi, Hui Wang, Minqun Du, Disang Feng, Liqing Wang, Rui Luo, Hangping Chen, Guilan Quan, Jianfeng Cai, Xin Pan, Chuanbin Wu, Chao Lu*. Guanidinium-rich lipopeptide functionalized bacteria-absorbing sponge as an effective trap-and-kill system for the elimination of focal bacterial infection. Acta Biomaterialia, 2022, 148:106-118. (IF=10.633)

 [8]Yuwei Zheng#, Yilang Yan#, Liming Lin, Qing He, Huihui Hu, Rui Luo, Dongyi Xian, Jieyi Wu, Yin Shi, Fanpu Zeng, Chuanbin Wu, Guilan Quan*, Chao Lu*. Titanium carbide MXene-based hybrid hydrogel for chemo-photothermal combinational treatment of localized bacterial infection. Acta Biomaterialia, 2022, 142: 113-123.(IF=10.633)

 [9]Peipei Yang#, Chao Lu#, Wanbing Qin, Minglong Chen, Guilan Quan, Hu Liu, Lili Wang, Xuequn Bai, Xin Pan*, Chuanbin Wu*. Construction of a core-shell microneedle system to achieve targeted co-delivery of checkpoint inhibitors for melanoma immunotherapy. Acta Biomaterialia, 2020, 104: 147-157. (IF=10.633)

 [10]Chao Lu#, Xin Li#, Wenquan Xia, Siheng Lu, Fei Tong, Hongjun Luo, Danyan Ye, Yanmei Zhang, Daojun Liu*. Poly(ε-benzyloxycarbonyl-L-lysine)-grafted branched polyethylenimine as efficient nanocarriers for indomethacin with enhanced oral bioavailability and anti-inflammatory efficacy. Acta Biomaterialia, 2016, 49: 434-443. (IF=10.633)

 [11]Jing Wang#, Chao Lu#, Yin Shi, Xiaoqian Feng, Biyuan Wu, Guilin Zhou, Guilan Quan, Xin Pan*, Jianfeng Cai*, and Chuanbin Wu*. Structural superiority of guanidinium-rich four-armed copolypeptides: Role of multiple peptide-membrane interactions in enhancing bacterial membrane perturbation and permeability. ACS Applied Materials & Interfaces, 2020, 12: 18363-18374. (IF=10.383)

 [12] Minghui Wang#, Xiaoqian Feng#, Ruixuan Gao, Peng Sang, Xin Pan, Lulu Wei, Chao Lu*, Chuanbin Wu*, Jianfeng Cai*. Modular design of membrane active antibiotics: From macromolecular antimicrobials to small scorpion-like peptidomimetics.Journal of Medicinal Chemistry, 2021, 64(14): 9894–9905.Featured Article(IF=8.039)


6、代表性专利:

 [1]陆超,吴传斌. 支化抗菌聚氨基酸及其制备方法与应用. 专利号ZL201910289123.4(已授权)

 [2]吴传斌施铟陆超,潘昕,林莉铭.一种抗菌肽脂质体制剂及其制备方法.专利号ZL201911378739.5(已授权)

 [3]陆超,罗芮,吴传斌,潘昕,周桂玲,权桂兰.针尖液、微针贴片及其制备方法与应用.专利号:202210259218.3

 [4] 陆超,吴传斌,江玲,罗芮. 防腐保鲜商标贴及其制备方法与应用.专利号:202210814648.7.


7、学术兼职

 [1] 期刊VIEWActa Materia MedicaMaterials FutureshLife和《今日药学》的青年编委、Exploration推广编辑、Pharmaceutics专题顾问和Moleules客座编辑

 [2] 期刊Molecules刊“Novel Antimicrobial Agents: Design, Synthesis and Activity”及专Microneedle-Mediated Diagnosis and Therapeutics of Diseases主编

 [3] 《药剂学实验教程》、《先进药剂学》编委

 [4] 国际控释协会、广东省药学会等多个学术组织会员

 [5] 中国药物制剂大会等多个学术会议的组委会成员

 [6] SmallNano LettersActa Biomaterialia等多个SCI杂志的审稿人

 [7] 广州新济药业顾问专家


8联系方式:

邮箱:

地址:广东省广州市番禺区兴业大道东855号暨南大学药学院

 ResearchGate:https://www.researchgate.net/profile/Chao-Lu-20/research

 ORCID: https://orcid.org/0000-0002-2118-8888